Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TSHR | P16473 | 2/20 | 0.55 |
| ▸ | BLM | P54132 | 2/20 | 0.55 |
| ▸ | NPSR1 | Q6W5P4 | 2/20 | 0.55 |
| ▸ | MEN1 | O00255 | 1/20 | 0.55 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.55 |
| ▸ | POLB | P06746 | 1/20 | 0.55 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.55 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.55 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.55 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.55 |
| ▸ | PMP22 | Q01453 | 1/20 | 0.55 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.55 |
| ▸ | GLS | O94925 | 1/20 | 0.50 |
| ▸ | FOLH1 | Q04609 | 2/20 | 0.47 |
| ▸ | SLC22A3 | O75751 | 1/20 | 0.46 |
| ▸ | HDAC3 | O15379 | 1/20 | 0.46 |
| ▸ | HDAC4 | P56524 | 1/20 | 0.46 |
| ▸ | HDAC1 | Q13547 | 1/20 | 0.46 |
| ▸ | HDAC7 | Q8WUI4 | 1/20 | 0.46 |
| ▸ | HDAC2 | Q92769 | 1/20 | 0.46 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2121870 | 0.88 | NAAA (0.59) | TSHRBLMNPSR1 | |
| SCHEMBL4876904 | 0.88 | NAAA (0.59) | TSHRBLMNPSR1 | |
| SCHEMBL5705007 | 0.88 | NAAA (0.59) | TSHRBLMNPSR1 | |
| SCHEMBL4886844 | 0.79 | NAAA (0.59) | CYP3A4 | |
| SCHEMBL5704957 | 0.79 | NAAA (0.59) | CYP3A4 | |
| SCHEMBL4881044 | 0.79 | NAAA (0.59) | CYP3A4 | |
| SCHEMBL10876855 | 0.79 | — | — | |
| SCHEMBL7947240 | 0.78 | TYR (0.57) | TSHRBLMNPSR1GLS | |
| SCHEMBL7939608 | 0.75 | ERCC1 (0.57) | TSHRBLMNPSR1MEN1CYP1A2 | |
| SCHEMBL7939628 | 0.75 | TSHR (0.57) | TSHRBLMNPSR1MEN1CYP1A2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1515943-B1 | USE OF ALKYLAMIDOMANDELATES AS FLAVOURINGS | SYMRISE GMBH & CO KG (DE) | 2006-08-30 | — | — | EP | claimed |
| US-20050208084-A1 | Use of alkylamidomandelates as flavourings | SYMRISE GMBH & CO. KG (DE) | 2005-09-22 | — | — | US | claimed |
| US-20080038386-A1 | Use of a liquid cooling sensate to provide a pungent, warming or tingling sensate composition | MOZA ASHOK K | 2008-02-14 | — | — | US | disclosed |
| US-20050208084-A1 | Use of alkylamidomandelates as flavourings | SYMRISE GMBH & CO. KG (DE) | 2005-09-22 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20050208084-A1 | Use of alkylamidomandelates as flavourings | HNMT, TAS2R7, PNMT | TSHR 4512/4885BLM 3923/4885NPSR1 2141/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.